Tess Burleson
CIK: 0001769749
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DCOY
Decoy Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
About Burleson Tess
Burleson Tess (SEC CIK 0001769749) files insider reports with the SEC as Director of Decoy Therapeutics Inc. (DCOY).
Signal8 holds 1 ownership filing by Burleson Tess, a Form 4, filed on Sep 2, 2026. Those filings report 1 transaction, the latest on Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Burleson Tess's filings is in HOUSTON, TX.
Recent filings by Burleson Tess
- Aug 31, 2026: Grant or award of DCOY shares (Form 4, code A).
Other insiders filing for Decoy Therapeutics Inc. (DCOY)
- Lieber Jonathan I, Director
- PIERCE FREDERICK II, Chief Executive Officer
- Marschel Peter Klaus, Chief Business Officer
- Rosenblum Mark J, Chief Financial Officer
- Hibner Barbara Louise, Chief Scientific Officer
- HANISH ARNOLD C, Director